Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism and Elimination of 14C-Lenvatinib in Advanced Solid Tumors
NCT02578316Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lenvatinib in solid tumor and lymphoma, sponsored by Eisai Co., Ltd. Primary endpoints: Maximum Plasma Concentration, Time of Maximum Plasma Concentration and 9 more. Started Jun 2009; status: completed.
02
Drugs
lenvatinib
03
Conditions
solid tumorlymphoma
Beyond the preview
Go deeper on NCT02578316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578316.